SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: Ariella who wrote (1075)7/22/1998 9:28:00 AM
From: NeuroInvestment  Read Replies (1) | Respond to of 1491
 
1) A clarification regarding the dosage reduction: it was a tactical decision based on the serum levels obtained from the first two doses, which diverged from expectations ( and actually were lower than anticipated). Based on the effects Pharmos thinks (based on results that they state remain blinded) are being obtained from HU211 on the first two cohorts, they decided that 300 would be too large a leap, and would risk hitting a downward slope of diminishing returns. Second, while the Israeli authorities had authorized up to 300mg, some IRBs at individual sites had only authorized up to 200mg, and time would have been consumed by revising those limits. The most important element is that PARS definitively states that the reduction was not due to any adverse effects emerging from the first two cohorts.
2) I would add what may by this point be a superfluous note of support and appreciation for the numerous postings made by Ariella on this thread, which are consistently thoughtful and well-informed,devoid of the blind boosterism that mars so many threads and messages.
NeuroInvestment (www.neuroinv.com)



To: Ariella who wrote (1075)7/22/1998 11:03:00 AM
From: ROBERT M. SILVER  Respond to of 1491
 
OK, so you are an old lady. Just trying to be polite.
Not an Israeli---Fine
Wont read my postings-Fine
Hope I dont permanently join the SI network=Fine
Never said that options would be converted immediately, Read the registration, These people have three years to exercise the options. Isnt that great?
And as to your righteous indignation, If you cant stand the heat get out of the kitchen.
Fortunately, there are those who appreciate my input.
Robert M. Silver



To: Ariella who wrote (1075)7/22/1998 11:19:00 AM
From: Ariella  Read Replies (2) | Respond to of 1491
 
To the thread: For the record about the S-3/A filed July 14, 1998 --

1) The number 6 million for the proposed maximum amount of common shares to be converted from the Preferred C series has a footnote (1).
It says, in direct quote from the document,

" Assumes conversion price for all the preferred stock at $0.83, which is estimated for the purpose of determining the maximum number of shares of Common Stock obtained upon conversion.."

Correct interpretation? Unless PARS gets down to $0.83/share, the ACTUAL number of shares added to the common stock base will be considerably less than 6 million. Try, say, 2 or 2.5 million.

2) The document listed a Proposed Maximum Offering Price of $2.53. That amount also has a footnote (3) listed after it. It says, in direct quote:

" Estimated solely for the purpose of calculating the registration fee. Proposed maximum offering price per share is estimated based upon the closing price of the Company's Common Stock listed on the Nasdaq SmallCap Market on July 7, 1998."

Correct interpretation? In no way has Castle Creek pre-announced a decision to sell at $2.53. The SEC simply wants some number chosen so it can get its fee and the number is taken, arbitrarily, from a date close to the filing of this document.

All this material is available free of charge at freeedgar.com. Patience and close reading is required to obtain useful information.



To: Ariella who wrote (1075)7/22/1998 4:47:00 PM
From: Ariella  Read Replies (1) | Respond to of 1491
 
OT: at 9:01 today, posted FNTN here as good stock Up 64% for the day.

Ariella

P.S. Apologies for talking about another stock on this thread.
Needed to crow a bit <VBG>



To: Ariella who wrote (1075)7/24/1998 2:14:00 AM
From: Stephen D. Wilson  Respond to of 1491
 
Ariella,

You go girl!!

I knew you could hold your own against that overzealous, pompous
neophyte. I like you could care less if this guy stays on the thread. You have given me the information I needed to stay in tune to what has been going on with the company (along with several other posters). I have been long on this stock for the last three and half years. I am looking forward to a very decent payoff. I have read this thread for many years and must say that you have always provided us with some of the most insightful, well-thought, and precise information. I am indebted to you for for the hard work you have put into this thread. Keep it up.

Steve